Lovastatin Tablet
Product Images NDC 71205-440

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 71205-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin Structural Formula (Image 1)

Lovastatin Structural Formula (Image 1)
Chemical structure of lovastatin, illustrating its molecular framework with multiple rings and functional groups, consistent with the active ingredient in the Lovastatin 20 mg oral tablets by Proficient Rx LP.*
FDA Label Image

Figure 1: Actue Major Coronary Events (primary Endpoint) (Image 2)

Figure 1: Actue Major Coronary Events (primary Endpoint) (Image 2)
Line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without events over years of follow-up. The graph compares outcomes of Lovastatin versus Placebo, indicating a 37% risk reduction with Lovastatin (p < 0.001). The y-axis represents the proportion of participants without event, and the x-axis shows years of follow-up up to 6 years.*
FDA Label Image

71205-440-30 (Image 4)

71205-440-30 (Image 4)
Label for Lovastatin 20 mg tablets, containing 30 tablets per bottle, labeled by Proficient Rx LP. The label includes NDC 71205-440-30, storage instructions, manufacturer information (Pliva Hrvatska d.o.o., Zagreb, Croatia), and notes the tablets are light blue, round, flat beveled, debossed with '576' and 'TEVA'. It is marked RX Only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.